Search Results
Search results for "mu-opioid receptor"
Results found for "mu-opioid receptor"
- GPCRs are not simple on-off switches: deep dive into GPCR-ligand interactions
GPCR activation typically occurs through the binding of agonists which stabilize receptor conformations The initial demonstration of spontaneous or "constitutive" receptor activity was reported for the β2- adrenergic receptor in 1984 (Cerione et al. 1984), where reconstitution of purified β2-adrenergic receptors Subsequently, opioid receptors were shown to constitutively activate Gi proteins in a membrane preparation in their orthosteric binding sites, such as chemokine receptors.
- 📰 GPCR Weekly News, February 26 to March 3, 2024
via single amino acid substitution G protein-coupled receptors: from radioligand binding to cellular dynamics of extramembrane domains in the β2 -adrenergic receptor β-Arrestin-independent endosomal cAMP Bicarbonate signalling via G protein-coupled receptor regulates ischaemia-reperfusion injury GPCRs in of potential TAAR1 agonist targeting neurological and psychiatric disorders: An in silico approach Opioid Commentary: Analyzing invertebrate bitopic cadherin G protein-coupled receptors that bind cry toxins
- 📰 GPCR Weekly News, December 4 to 10, 2023
and Signaling Distinct beta-arrestin coupling and intracellular trafficking of metabotropic glutamate receptor homo- and heterodimers Structural basis of G protein-Coupled receptor CMKLR1 activation and signaling induced by a chemerin-derived agonist Functional profiling of the G protein-coupled receptor C3aR1 reveals Binders, Drugs, and more Design and structural validation of peptide-drug conjugate ligands of the kappa-opioid receptor GPCRs in Neuroscience Research progress on the role of orphan receptor GPR139 in neuropsychiatric
- 📰 GPCR Weekly News, April 17 to 23, 2023
GPCR Activation and Signaling How can we improve the measurement of receptor signaling bias? The relaxin receptor RXFP1 signals through a mechanism of autoinhibition. Regulation of the pro-inflammatory G protein-coupled receptor GPR84. GPCR Binders, Drugs, and more Development of a 5-HT7 receptor antibody for the rat: the good, the bad GPCRs in Neuroscience G protein coupled receptors as targets for transformative neuropsychiatric therapeutics
- 📰 GPCR Weekly News, April 15 to 21, 2024
congrats to: Luca Franchini and Cesare Orlandi for their research on Deorphanization of G Protein Coupled Receptors Drugs, and more Identification of 1,3,8-triazaspiro[4.5]decane-2,4-dione Derivatives as a Novel Delta Opioid Receptor-Selective Agonist Chemotype GPCRs in Neuroscience Calcium-sensing receptor regulates Kv7 channels larval metamorphosis and spawning behavior in Pacific abalone The role of orphan G protein-coupled receptors enables sensitive detection of fungal pathogens In Silico Analyses of Vertebrate G-Protein-Coupled Receptor
- 📰 GPCR Weekly News, July 31 to August 6, 2023
Nichola J Smith's investigation: Gene expression of TAS1R taste receptors for cardiometabolic disease psychosis risk factor RBM12 encodes a novel repressor of GPCR/cAMP signal transduction The relaxin receptor RXFP1 signals through a mechanism of autoinhibition To probe the activation mechanism of the Delta opioid receptor by an agonist ADL5859 started from inactive conformation using molecular dynamic simulations Development of an Affinity-Based Probe to Profile Endogenous Human Adenosine A3 Receptor Expression
- 📰 GPCR Weekly News - January 9 to 15, 2023
GPCR Binders, Drugs, and more Modelling altered signalling of G-protein coupled receptors in inflamed Protease-activated receptor 2 (PAR2)-targeting peptide derivatives for positron emission tomography ( Structural Understanding of Peptide-Bound G Protein-Coupled Receptors: Peptide-Target Interactions. molecular associations in clathrin-coated pit regulate β-arrestin-mediated MAPK signaling downstream of μ-opioid receptor.
- 📰 GPCR Weekly News, May 13 to 19, 2024
their work on The far extracellular CUB domain of the adhesion GPCR ADGRG6/GPR126 is a key regulator of receptor midgut muscles The far extracellular CUB domain of the adhesion GPCR ADGRG6/GPR126 is a key regulator of receptor more Silicon-Rhodamine Functionalized Evocalcet Probes Potently and Selectively Label Calcium Sensing Receptors pharmacology Structural and dynamic insights into the activation of the μ-opioid receptor by an allosteric modulator Structural Insights into Partial Activation of the Prototypic G Protein-Coupled Adenosine A2A Receptor
- 📰 GPCR Weekly News, April 22 to 28, 2024
GPCR News from April 22nd to 28th, 2024 Adhesion GPCRs Dysfunction of the adhesion G protein-coupled receptor peptide signaling durations and the structural determinants thereof Ubiquitin-driven G Protein-Coupled Receptor vitro studies GPCRs in Neuroscience Phytocannabinoids in neuromodulation: from omics to epigenetics The receptor Methods & Updates in GPCR Research Single-chain fluorescent integrators for mapping G-protein-coupled receptor The nematode-trapping fungus Arthrobotrys oligospora detects prey pheromones via G protein-coupled receptors
- Knowing When to Walk, Knowing When to Run: Lessons from the Bench
A Final Aha Moment: Try the Crazy Idea When a collaborator offered a neuroma model (one where opioids
- TRPM3 in the eye and in the nervous system - from new findings to novel mechanisms
August 2022 "The calcium-permeable cation channel TRPM3 can be activated by heat and the endogenous steroid pregnenolone sulfate. TRPM3's best understood function is its role as a peripheral noxious heat sensor in mice. However, the channel is expressed in various tissues and cell types including neurons as well as glial and epithelial cells. TRPM3 expression patterns differ between species and change during development. Furthermore, a plethora of TRPM3 variants that result from alternative splicing have been identified and the majority of these isoforms are yet to be characterized. Moreover, the mechanisms underlying regulation of TRPM3 are largely unexplored. In addition, a micro-RNA gene (miR-204) is located within the TRPM3 gene. This complexity makes it difficult to obtain a clear picture of TRPM3 characteristics. However, a clear picture is needed to unravel TRPM3's full potential as experimental tool, diagnostic marker and therapeutic target. Therefore, the newest data related to TRPM3 have to be discussed and to be put in context as soon as possible to be up-to-date and to accelerate the translation from bench to bedside. The aim of this review is to highlight recent results and developments with particular focus on findings from studies involving ocular tissues and cells or peripheral neurons of rodents and humans." Read more at the source #DrGPCR #GPCR #IndustryNews
- 📰 GPCR Weekly News, April 10 to 16, 2023
GPCRs in Cardiology, Endocrinology, and Taste G-protein coupled receptor 19 (GPR19) knockout mice display Neurotensin receptor 1-biased ligand attenuates neurotensin-mediated excitation of ventral tegmental Methods & Updates in GPCR Research Activity Map and Transition Pathways of G Protein-Coupled Receptor Computational insights into ligand-induced G protein and β-arrestin signaling of the dopamine D1 receptor In situ visualization of opioid and cannabinoid drug effects using phosphosite-specific GPCR antibodies
- 📰 GPCR Weekly News, July 24 to July 30, 2023
Adhesion GPCRs Dual role of the adhesion G-protein coupled receptor ADRGE5/CD97 in glioblastoma invasion G protein-coupled receptor-mediated membrane targeting of PLCγ2 is essential for neutrophil chemotaxis Monoacylglycerol Lipase Protects the Presynaptic Cannabinoid 1 Receptor from Desensitization by Endocannabinoids Endocrinology, and Taste Insights on discovery, efficacy, safety and clinical applications of ghrelin receptor GPCRs in Oncology and Immunology Interplay between G protein-coupled receptors and nanotechnology.
- 📰 GPCR Weekly News, January 29 to February 4, 2024
flexible cadherin ectodomain GPCR Activation and Signaling GPCR signaling bias: an emerging framework for opioid Binders, Drugs, and more Insights on discovery, efficacy, safety and clinical applications of ghrelin receptor capromorelin in veterinary medicine GPCRs in Cardiology, Endocrinology, and Taste The role of P2Y6 receptor in the pathogenesis of cardiovascular and inflammatory diseases β-adrenergic receptor signaling mediated GIO Therapeutics, founded by Cumulus Oncology, to develop therapeutics targeting G protein-coupled receptors
- 📰 GPCR Weekly News, February 20 to 26, 2023
GPCR Activation and Signaling Coupling between GPR143 and dopamine D2 receptor is required for selective potentiation of dopamine D2 receptor function by L-3,4-dihydroxyphenylalanine in the dorsal striatum Gαi-derived peptide binds the µ-opioid receptor. A growing understanding of the role of muscarinic receptors in the molecular pathology and treatment Gpr84 PhD Studentship - Insight Into The Neuroprotective Function Of The Prostaglandin Receptor Ep2
- Nanobodies: New Dimensions in GPCR Signaling Research
Nb39: This nanobody was identified for the μ-opioid receptor (μOR) and also increased the affinity of receptor in a ground-state-like. Nanobodies to Study G Protein-Coupled Receptor Structure and Function. Activation and allosteric modulation of a muscarinic acetylcholine receptor. Structural basis for chemokine recognition and activation of a viral G protein-coupled receptor.
- 📰 GPCR Weekly News, March 25 to March 31, 2024
includes congrats to: Junyi Liang, Niña Caculitan, and Adam W Smith for their research on β2-adrenergic receptor and VPAC2 identified by molecular dynamics simulations Preassembly of specific Gβγ subunits at GABAB receptors receptor Computational modelling of dynamic cAMP responses to GPCR agonists for exploration of GLP-1R potassium channel signaling and pain homeostasis GPCRs in Oncology and Immunology The β2-adrenergic receptor chromatographic performance Fluorine-19 labeling of the tryptophan residues in the G protein-coupled receptor
- 📰 GPCR Weekly News
Quantification of changes in human islet G protein-coupled receptor mRNA expression in obesity. receptor family. Cryo-EM structure of G-protein-coupled receptor GPR17 in complex with inhibitory G protein. Molecular insights into the mechanism of sugar-modified enkephalin binding to opioid receptors. Current Technologies To Understand G-Protein-Coupled Receptor Molecular Pharmacology.
- On-cell nuclear magnetic resonance spectroscopy to probe cell surface interactions
spectroscopy to characterize ligand interactions with cell surface membrane proteins such as G-protein coupled receptors (GPCRs) and receptor tyrosine kinases. delineation of ligands involved in binding, ligand bound-state conformational determination, evaluation of receptor structuring and dynamics, and inference of distance constraints characteristic of the ligand-receptor
- 📰 GPCR Weekly News, January 30 to February 5, 2023
Simultaneous activation of CXC chemokine receptor 4 and histamine receptor H1 enhances calcium signaling Functional expression of oxytocin receptors in pulp-dentin complex. Patching holes in the mechanism of opioid tolerance. Development and challenges in the discovery of 5-HT1A and 5-HT7 receptor ligands. Cryo-EM structure of orphan G protein-coupled receptor GPR21.
- Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling
G protein-coupled receptors (GPCRs) are integral membrane proteins crucial for sensing extracellular These receptors initiate intracellular signaling cascades upon activation, ultimately regulating a myriad Gilman, A.G., G proteins: transducers of receptor-generated signals. Zhao, P., et al., Activation of the GLP-1 receptor by a non-peptidic agonist. Galés, C., et al., Real-time monitoring of receptor and G-protein interactions in living cells.Â
- Target Residence Time: The Hidden Driver of In Vivo Efficacy
tissues like tumors slows offset and improves therapeutic window ✅ Examples of how rebinding in dense receptor Diffusion, Rebinding, and Receptor Density: The In Vivo Edge This lecture shows how tissue architecture And when receptors are dense (like GPCRs on membranes), this rebinding hits the collisional limit , where Subscribe to The Kenakin Brief today ➤ #TargetResidenceTime #DrugBindingKinetics #PKPDdissociation #ReceptorPharmacology
- Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right
Must-read publications:  β-arrestin2-biased allosteric modulator for pain beyond opioids & GPR3 regulated Physiological relevance:  Fluorescent ligands can retain receptor integrity—critical when signaling readouts
- John Streicher talks about his work on terpenes found in cannabis as these may be a novel way to ...
These compounds may be a novel way to treat pain without the negative side effects of cannabinoids or opioids
- When the Islet Lit Up: Advancing GPCR Imaging in Native Tissue
Could they map receptor heterogeneity across the islet? Could they quantify plasma membrane vs. intracellular receptor pools? The tools didn’t simply visualize receptors. mapping Super-resolution imaging of receptor nanodomains AI-assisted probe design Multi-receptor visualization Not one receptor at a time. Not one color. Not one imaging depth.
- From One to Many: How a GPCR Curiosity Became a Field-Wide Toolkit
Watch Episode 167 What started with a single receptor became a toolset for an entire superfamily. Tom Sakmar didn’t set out to map GPCR-RAMP interactions across hundreds of receptors. began with a phone call (from Bruce Merrifield, no less) encouraging Sakmar to work on the glucagon receptor A Long-Term Obsession, Reframed Sakmar’s lab had been focused on the secretin receptor family  for decades It was graduate student Emily Lorenzen  who helped frame the next step: stop studying one receptor at
- Using Live-cell High-Content Screening to Characterize CB2 Ligands: Insights From 16 Synthetic Cannabinoids
The cannabinoid receptor type 2 (CB2R) has emerged as a compelling target across inflammation, immune Subcellular membrane mixtures, altered receptor conformations, and non-specific interactions introduce By quantifying ligand–receptor interactions directly in intact cells, HCS allows researchers to observe In a recent collaborative study, 16 synthetic cannabinoid receptor agonists (SCRAs) were evaluated using Because imaging is captured across thousands of intact cells, each measurement incorporates receptor
- Radioligands vs. Fluorescent Ligands: Binding Assays
Understanding receptor-ligand interaction is key in drug discovery and biomedical research. Besides binding assays, they can also be used to study receptor density, binding sites and ligand kinetics interactions, particularly in pharmacokinetic and receptor occupancy studies. They are useful tools to visualize receptors in native or transfected cells, whether living or fixed. Probing the pharmacology of G protein-coupled receptors with fluorescent ligands.
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
Azietaku , our great contributor, for his article Class B1 GPCR Dimerization: Unveiling Its Role in Receptor variant in RGS18 candidate for a familial mild bleeding syndrome Fusarium graminearum Ste2 and Ste3 Receptors Heterodimerization when Expressed Heterologously in Saccharomyces cerevisiae The beta 2 adrenergic receptor Neuronal Precursor Cells Derived from Patients Diagnosed with Schizophrenia Sphingosine 1-phosphate receptor the CaSR gene Reviews, GPCRs, and more Insight into structural properties of viral G protein-coupled receptors
- Fluorescence Polarization in GPCR Research
This makes them very useful for GPCR drug discovery, since receptors are a lot bigger than their small where they used CELT-419 for D3 dopamine receptor binding assays in baculoviruses. 3.      extended periods (at least 60 to 90minutes), being limited by the stability of the fluorescent ligand or receptor and protein matters (for the rotation to be slowed), not the distance between the protein, donor and acceptor













